Eric Enson > Jones Day > Los Angeles, United States > Lawyer Profile

Jones Day
555 S FLOWER ST
FIFTIETH FLOOR
LOS ANGELES, CA 90071
United States

Lawyer Rankings

United States > Antitrust > Cartel

Jones Day‘s John Majoras (based in Washington DC) continues to work with Los Angeles’ Eric Enson and the Tokyo office to advise a manufacturer on the landmark DOJ investigation into the global auto parts cartel. In the pharmaceutical space, Michael Knight and Geoffrey Oliver, who are also based in DC, represented a pharmaceutical company in an FTC investigation of a drug used to treat opioid addiction, as well as in a private class action brought by wholesalers on the same grounds. Bruce McDonald sits in Houston and is currently counseling an oil and gas client on an internal investigation into the pricing practices of a newly acquired subsidiary. San Francisco-based Craig Waldman jointly leads the global practice with Bernard Amory, who sits in the Brussels office. Marc Siegel in San Francisco is another name to note. David Wales moved to Skadden, Arps, Slate, Meagher & Flom LLP.

United States > Antitrust > Civil litigation/class actions: defense

Craig Waldman, who splits his time between San Francisco and Silicon Valley, and Brussels-based Bernard Amory jointly lead the global antitrust practice at Jones Day. In a recent highlight, Washington DC-based John Majoras and Los Angeles’ Eric Enson are currently collaborating with the Tokyo office to represent NGK and its US subsidiary in several putative class actions arising from the high-profile global investigation into the auto parts cartel. Railway equipment supplier Wabtec appointed a group led by Waldman and David Kiernan – who is based in San Francisco – to defend it in a putative class action brought by current and former employees alleging the client engaged in a conspiracy to depress wages through ‘no-poach’ agreements with Knorr-Bremse. Chicago-based Paula Render is acting for Deutsche Bank regarding the class action claiming anti-competitive behavior in the trading of interest rate swaps on electronic exchanges. Other key names include Cleveland-based Michelle Fischer and DC’s Michael Knight, who is advising a pharmaceutical company on multi-district class action litigation brought by purchasers alleging the client monopolized sales of a drug by engaging in ‘product hop’ and hindering the entry to market of generics manufacturers. Michael Gleason is also a key name to note. David Wales moved to Skadden, Arps, Slate, Meagher & Flom LLP.